Percutaneous kyphoplasty for stage Ⅲ Kümmell＇s disease with no neurological symptom
10.3760/cma.j.issn.1671-7600.2019.10.012
- VernacularTitle: 经皮椎体后凸成形术治疗无神经症状性Ⅲ期Kümmell病
- Author:
Yijie LIU
1
;
Sen YANG
;
Xuefeng LI
;
Weimin JIANG
;
Renjie LI
;
Heng WANG
;
Huaqing GUAN
;
Jie CHEN
;
Genlin WANG
;
Huilin YANG
Author Information
1. Department of Orthopaedics, The First Hospital Affiliated to Soochow University, Suzhou 215006, China
- Publication Type:Clinical Trail
- Keywords:
Vertebroplasty;
Kyphosis;
Spinal cord compression;
Kümmell’s disease
- From:
Chinese Journal of Orthopaedic Trauma
2019;21(10):888-893
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the clinical efficacy of percutaneous kyphoplasty (PKP) in the treatment of stage Ⅲ Kümmell＇s disease with no neurological symptom.
Methods:From January 2009 to June 2018, 45 patients underwent PKP for stage Ⅲ Kümmell＇s disease with no neurological symptom at Department of Orthopaedics, The First Hospital Affiliated to Soochow University. They were 12 males and 33 females, aged from 61 to 85 years (average, 70.9 years). Their visual analog scale (VAS) scores for back pain, Oswestry disability indexes (ODI), heights of fractured vertebrae and kyphosis cob angles were recorded and compared between preoperation, one day, 3 months and final follow-up after operation.
Results:All the 45 patients were followed up for 12 to 48 months (average, 28.0 months). Their VAS scores (2.4±0.7, 2.2±0.7 and 2.3±0.6), ODI sores (34.7±6.8, 34.2±6.5 and 34.1±6.6) and cobb angles (15.7°±2.2°, 15.8°±2.2° and 15.9°±2.4°) at one day, 3 months and final follow-up after operation were significantly lower than those (8.2±1.1, 75.3±9.0 and 25.2°±3.9°) before operation (P<0.001). Their anterior height ratios of the fractured vertebra (54.0%±4.3%, 53.7%±4.2% and 53.6%±4.0%) and median height ratios of the fractured vertebra (56.8%±4.0%, 56.5%±3.9% and 56.6%±3.9%) at one day, 3 months and final follow-up after operation were significantly higher than those (25.8%±3.9% and 27.2%±3.1%) before operation (P<0.001). The rate of cement leakage was 13.3%(6/45). No patients had neurological symptoms after operation.
Conclusion:PKP is a minimally invasive, safe and effective treatment for stage Ⅲ Kümmell's disease with no neurological symptom, because it can relieve the symptoms of the patients, restore the height of the fractured vertebral body and reduce the local kyphosis cobb angle.
